proline has been researched along with Astrocytoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| D'Cruze, L; Ganesh, K; Pacharla, H; Padmavathy, KP; Pitani, R; Prathiba, D; Rayala, SK; Saravanan, R; Venkatraman, G; Venu, A; Vuttaradhi, VK | 1 |
| Liu, Y; Luo, Y; Wei, S; Zou, Q | 1 |
| Ahn, YS; Kim, CH; Kim, DG; Kim, HS; Kim, I; Lee, J; Seo, GH | 1 |
3 other study(ies) available for proline and Astrocytoma
| Article | Year |
|---|---|
Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Co-Repressor Proteins; Female; Glutamic Acid; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Proline; Transcription Factors | 2021 |
Stachydrine suppresses viability & migration of astrocytoma cells via CXCR4/ERK & CXCR4/Akt pathway activity.
Topics: Adolescent; Antineoplastic Agents; Apoptosis; Astrocytoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; G1 Phase Cell Cycle Checkpoints; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proline; Proto-Oncogene Proteins c-akt; Receptors, CXCR4 | 2018 |
Inhibitory effect of zinc on hypoxic HIF-1 activation in astrocytes.
Topics: Antineoplastic Agents; Astrocytoma; Cell Line, Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Erythropoietin; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Proline; Protein Transport; Thiocarbamates; Time Factors; Zinc Sulfate | 2008 |